| CAS ID: | 376348-65-1 |
| Molecular Formula: | C29H41F2N5O |
| Molecular Weight: | 513.7 g/mol |
| Monoisotopic Mass: | 513.3279 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | CELSENTRI | MARAVIROC | SELZENTRY | UK-427857 | Rel-Maraviroc |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25-,26-/m0/s1 | See All |
| InChI Key: | GSNHKUDZZFZSJB-QYOOZWMWSA-N | |
| Smiles: | CC(C)c1nnc(C)n1[C@@H]2C[C@H]3CC[C@@H](C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)c5ccccc5 | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT01908660 | Disease | Liver fibrosis |
| Phase | Status | Completed | |
| First Received | July 26, 2013 | Last Verified | November 11, 2015 |
| Sponsor | Valme University Hospital | ||
| PubChem: | 3002977 |
| ChEMBL: | CHEMBL1201187 |